glp 1 zepbound tirzepatide FDA Crackdown Puts Pressure on GLP-1 Compounders, Telehealth Providers Oksana Aron, M.D., Medical Weight

Ro Offers Eli Lilly's Foundayo, the Newest GLP-1 Innovation Foundayo gives patients a new once daily pill option and expands Ros comprehensive weight loss formulary April 9, 2026 Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Companys newest oral GLP-1 innovation on the Ro platform, adding to Ros already comprehensive formulary of FDA-approved GLP-1s

GLP-1 medications can be both supportive and challenging when planning surgery

Note : Learn how retinol serums and creams differ to choose the appropriate formulation

This leads to fewer bowel movements, drier and harder stools, and a build-up that gets more uncomfortable over time